NewAmsterdam Pharma Co N.V. NAMS
- obicetrapib — Atherosclerotic Cardiovascular Disease NDA Submitted
- obicetrapib — Heterozygous Familial Hypercholesterolemia NDA Submitted
- obicetrapib — Type 2 Diabetes Phase 3
- obicetrapib — Alzheimer's Disease Phase 2
- obicetrapib — Dyslipidemia Phase 3
- Ubeslo — Primary Hypercholesterolemia NDA Submitted